As of 2025-12-31, the Intrinsic Value of Design Therapeutics Inc (DSGN) is -5.92 USD. This DSGN valuation is based on the model Peter Lynch Fair Value. With the current market price of 9.79 USD, the upside of Design Therapeutics Inc is -160.47%.
Based on its market price of 9.79 USD and our intrinsic valuation, Design Therapeutics Inc (DSGN) is overvalued by 160.47%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.92 - -5.92 | -5.92 | -160.47% |
| P/E | (19.47) - (20.63) | (19.83) | -302.6% |
| DDM - Stable | (13.79) - (65.87) | (39.83) | -506.9% |
| DDM - Multi | (9.95) - (37.00) | (15.69) | -260.3% |
| Market Cap (mil) | 557.64 |
| Beta | 0.77 |
| Outstanding shares (mil) | 56.96 |
| Enterprise Value (mil) | 542.55 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.81% |
| Cost of Debt | 5.00% |
| WACC | 5.85% |